New Cambridge spin-out raises $11 million in funding to develop revolutionary new drug for thrombosis, which causes heart attacks and strokes.
Drugs that do not represent value for money or are medically unproven may be increasingly reaching one of Europe’s largest pharmaceutical markets...
Academics advocate for changes to how we development better treatments for mental health.
Research provides insight into novel approach which could be used in pharmaceutical drug synthesis.
A new study reveals how drug reimbursement policy in Poland is leaving gaping loopholes for pharmaceutical firms to exploit, raising questions about...
A pioneering commercial and R&D relationship between the Department of Chemistry and a leading provider of scientific software solutions brings...